300318.SZ Stock Analysis
30
Uncovered
Beijing Bohui Innovation Biotechnology Group Co Ltd is uncovered by Eyestock quantitative analysis.
Rating
To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.
Low score
Beijing Bohui Innovation Biotechnology Group Co., Ltd. engages in the research and development, production, sale, and service of clinical laboratory analysis products. The company is headquartered in Beijing, Beijing and currently employs 1,652 full-time employees. The company went IPO on 2012-05-23. The firm operates two major reporting segments. The Inspection and Testing segment is mainly engaged in the research and development, production and sales of inspection instruments and inspection reagents. The firm's products for medical institutions mainly involve in vitro diagnostic testing, including human trace element testing and human papillomavirus (HPV) testing. The firm's testing equipment for non-medical institutions is mainly small mass spectrometers and related products. The Biological Products segment is mainly blood products, which can be divided into products such as albumin, immunoglobulin, coagulation factors and vaccines. The firm distributes its products within the domestic market and to overseas market.